Use of standard imaging techniques for prediction of postrevascularization functional recovery in patients with heart failure

Journal of Cardiac Failure

Volumn 5, Issue 4, 1999, Pages 334-346

  Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033389179     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)91338-6     Document Type: Review

References (89)

1. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D: Survival after onset of congestive heart failure in Framingham subjects. Circulation 1993;88:107-15
2. Ho KKL, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22:6A-13A
3. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M, Phelps ME, Schelbert HR: Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-63
4. Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J: Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987;10: 557-67
5. Louie HW, Laks H, Milgalter E, et al.: Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84:III290-5
6. Zeft HJ, Friedberg H, King JF, Manley JC, Huston JH, Johnson WD: Reappearance of anterior QRS forces after coronary bypass surgery; an electrovectorcardiographic study. Am J Cardiol 1975;36:163-8
7. Liu P, Keiss MC, et al.: The persistent defect on exercise thallium imaging and its fate after myocardial revascularization: does it represent scar or ischemia? Am Heart J 1985;110:996-1002
8. McCall D, Zimmer LJ, Katz AM: Kinetics of thallium exchange in cultured rat heart cells. Circ Res 1985;56: 370-80
9. Cloninger K, DePuey EG, Garcia EV, et al: Incomplete redistribution in delayed thallium-201 single-photon emission computed tomographic (SPECT) images: an overestimation of myocardial scarring. J Am Coll Cardiol 1988; 12:955-62
10. Dilsizian V, Rocco TP, Freedman NM, et al.: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6
11. Ohtani H, Tamaki N, Yonekura Y, et al: Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;15:394-9
12. Tamaki N, Ohtani H, Yamashita K, et al.: Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32:673-8
13. Haque T, Furukawa T, Takahashi M, Kinoshita M: Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging. Am Heart J 1995;130:553-63
14. Arnese M, Cornel JH, Salustri A, et al.: Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995;91: 2748-52
15. Vanoverschelde JL, D'Hondt AM, Marwick T, et al.: Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low-dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-42
16. Bax JJ, Cornel JH, Visser FC, et al.: Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28:558-64
17. Dilsizian V, Bonow RO: Differential uptake and apparent 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Circulation 1992; 85:1032-8
18. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y: Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:18-24
19. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW: Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41
20. Marzullo P, Parodi O, Reisenhofer B, et al.: Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72
21. Alfieri O, La Canna G, Giubbini R, Pardini A, Zogno M, Fucci C: Recovery of myocardial function. The ultimate target of coronary revascularization. Eur J Cardiothorac Surg 1993;7:325-30
22. Udelson JE, Coleman PS, Metherall J, et al: Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 210Tl and 99m-Tc-sestamibi. Circulation 1994;89:2552-9
23. Charney R, Schwinger ME, Chun J, et al.: Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128: 864-9
24. Marzullo P, Sambuceti G, Parodi O, et al.: Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. J Nucl Cardiol 1995;2:309-16
25. Perrone-Filardi P, Pace L, Prastaro M, et al.: Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94: 2712-9
26. Qureshi U, Nagueh SF, Afridi I, et al: Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation 1997;95:626-35
27. Zimmermann R, Mall G, Rauch B, et al: Residual 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation 1995;91: 1015-21
28. Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V: Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization. Circulation 1998;98:501-8
29. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL: Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991;83:26-37
30. Marzullo P, Parodi O, Reisenhofer B, et al.: Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72
31. Gonzalez P, Massardo T, Munoz A, et al.: Is the addition of ECG gating to technetium-99m sestamibi SPECT of value in the assessment of myocardial viability? An evaluation based on two-dimensional echocardiography following revascularization. Eur J Nucl Med 1996;23: 1315-22
32. Marzullo P, Sambuceti G, Parodi O: The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992;33:1925-30
33. Maes AF, Borgers M, Flameng W, et al.: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997;29:62-8
34. Maublant JC, Citron B, Lipiecki J, et al.: Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J 1995;129:306-14
35. Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF: Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36: 1994-2000
36. Maurea S, Cuocolo A, Soricelli A, et al.: Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med 1995;36:1953-60
37. Bisi G, Sciagra R, Santoro GM, Fazzini PF: Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9
38. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M: Identification of viable myocardium in patients with chronic coronary disease: comparison with thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992; 33:505-11
39. Murray G, Schad N, Ladd W, et al.: Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. J Nucl Med 1992;33:1269-77
40. Murray GL, Schad NC, Magill HL, Vander Zwaag R: Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction. J Nucl Med 1994;35:43S-8S
41. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A: Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-65
42. Schroter G, Schneider-Eicke J, Schwaiger M: Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging. Herz 1994;19: 42-50
43. Bax JJ, Visser FC, Blanksma PK, et al.: Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 1996;37:1631-6
44. Srinivasan G, Kitsiou AN, Bacharach SL, Bartlett ML, Miller DC, Dilsizian V: [18F]fluorodeoxyglucose single-photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? Circulation 1998;97:843-50
45. Rasmussen S, Corya B, Feigenbaum H, Knoebel S: Detection of myocardial scar tissue by M-mode echocardiography. Circulation 1978;57:230-6
46. Pasquet A, Lauer MS, Williams MJ, Secknus MA, Lytle B, Marwick TH: Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction: impact of preoperative myocardial function, perfusion, and metabolism. Eur Heart J 1999 (in press)
47. Fudo T, Kambara H, Hashimoto T, et al.: FIS deoxyglucose and stress N13 ammonia positron emission tomography in anterior wall healed myocardial infarction. Am J Cardiol 1988;61:1191-7
48. Armstrong WF: "Hibernating" myocardium: asleep or part dead? J Am Coll Cardiol 1996;28:530-5
49. Lieberman AN, Weiss JL, Jugdutt BI, et al.: Relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981;63: 739-46
50. Weissman NJ, Rose GA, Foster GP, Picard MH: Effects of prolonging peak dobutamine dose during stress echocardiography. J Am Coll Cardiol 1997;29:526-30
51. Varga A, Ostojic M, Djordjevic-Dikic A, et al.: Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J 1996;17:629-34
52. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA: Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91: 663-70
53. Secknus M-A, Marwick TH: Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years. J Am Coll Cardiol 1997;29:1234-40
54. Cornel JH, Balk AH, Boersma E, et al.: Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996;9:27-32
55. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31
56. Smart SC, Sawada S, Ryan T, et al.: Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15
57. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M: Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993;72:124G-30G
58. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6
59. Watada H, Ito H, Oh H, et al.: Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994;24:624-30
60. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O: Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26
61. Perrone-Filardi P, Pace L, Prastaro M, et al.: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91: 2556-65
62. Senior R, Glenville B, Basu S, et al.: Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995;74:358-64
63. Bolognese L, Antoniucci D, Rovai D, et al.: Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996;28:1677-83
64. Poli A, Previtali M, Lanzarini L, et al.: Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis. Heart 1996;75:240-6
65. Furukawa T, Haque T, Takahashi M, Kinoshita M: An assessment of dobutamine echocardiography and end-diastolic wall thickness for predicting postrevascularization functional recovery in patients with chronic coronary artery disease. Eur Heart J 1997;18:798-806
66. Cornel JH, Bax JJ, Elhendy A, Reijs AE, Fioretti PM: Dobutamine stress-redistribution-reinjection versus rest-redistribution thallium-201 SPECT in the assessment of myocardial viability. Int J Card Imaging 1997;13:59-64
67. Nagueh SF, Vaduganathan P, Ali N, et al.: Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29:985-93
68. Kaul S: Response of dysfunctional myocardium to dobutamine. The eyes see what the mind knows. J Am Coll Cardiol 1996;27:1608-11
69. Sun KT, Czernin J, Krivokapich J, et al.: Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996;94:3146-54
70. Kaul S: Myocardial contrast echocardiography. Curr Prob Cardiol 1998;22:549-640
71. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S: An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. New Engl J Med 1992;327:1825-31
72. Multicenter Postinfarction Research Group: Risk stratification and survival after myocardial infarction. New Engl J Med 1983;309:331-6
73. Cornel JH, Bax JJ, Elhendy A, et al.: Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998;31:1002-10
74. Di Carli MF, Davidson M, Little R, et al.: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73:527-33
75. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, Maclntyre WJ: Prediction by postexercise fluoro-18-deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992;69: 854-9
76. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams MJ, Lytle BW: Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750-8
77. Lee KS, Marwick TH, Cook SA, et al.: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94
78. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65
79. Cuocolo A, Petretta M, Nicolai E, et al.: Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998;25:60-8
80. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M: Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800
81. Basu S, Senior R, Raval U, Lahiri A: Superiority of nitrateenhanced 201Tl over conventional redistribution 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis. Circulation 1997;96:2932-7
82. Zafrir N, Leppo JA, Reinhardt CP, Dahlberg ST: Thallium reinjection versus standard stress/delay redistribution imaging for prediction of cardiac events. J Am Coll Cardiol 1998;31:1280-5
83. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH: Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27:132-9
84. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH: Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6
85. Picano E, Sicari R, Landi P, et al.: Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after acute uncomplicated myocardial infarction: A dobutamine stress echocardiographic study. Circulation 1998;98:1078-84
86. Kostopoulos KG, Kranidis AI, Bouki KP, et al.: Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201TI imaging after dipyridamole infusion. Angiology 1996;47:1039-46
87. Elsasser A, Muller KD, Vogt A, et al.: Assessment of myocardial viability: dobutamine echocardiography and thallium-201 single-photon emission computed tomographic imaging predict the postoperative improvement of left ventricular function after bypass surgery. Am Heart J 1998;135:463-75
88. Le Feuvre C, Baubion N, Aubry N, Metzger JP, de Vernejoul P, Vacheron A: Assessment of reversible dyssynergic segments after acute myocardial infarction: dobutamine echocardiography versus thallium-201 single-photon emission computed tomography. Am Heart J 1996;131:668-75
89. Rovai D, Zanchi M, Lombardi M, et al.: Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography. Eur Heart J 1996; 17:296-301